Ingrid Kane

Chief Tech/Sci/R&D Officer at SIGHT SCIENCES, INC.

Health Technology

Health Services

Consumer Services

Profile

Ingrid Kane is currently the Vice President-Global Medical Affairs at Sight Sciences, Inc. Previously, she worked as the Vice President-Medical Affairs at iScience Interventional Corp.
She holds a doctorate degree from the University of Charles.

Ingrid Kane active positions

Companies	Position	Start
SIGHT SCIENCES, INC.	Chief Tech/Sci/R&D Officer	-

All active positions of Ingrid Kane

Former positions of Ingrid Kane

Companies	Position	End
iScience Interventional Corp. iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA.	Chief Tech/Sci/R&D Officer	-

See the detail of Ingrid Kane's experience

Training of Ingrid Kane

University of Charles

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ingrid Kane's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SIGHT SCIENCES, INC.	Health Technology

Private companies	1
iScience Interventional Corp. iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA.	Health Services